<?xml version="1.0" encoding="UTF-8"?>
<p>Here, we summarize key scientific, ethical, and feasibility considerations relevant to the design of Phase 3 vaccine trials in epidemic situations. Trial design choices are discussed, highlighting the benefits and drawbacks of each in given contexts.</p>
